Literature DB >> 11173638

Lymph Node Reaction to Cancer. (Immunohistochemical and Ultrastructural Study).

Dmitry E Tsyplakov1, Semion V Petrov, Roman N Kulagin.   

Abstract

A total of 153 regional lymph nodes obtained from 50 patients, operated for gastric, lung, breast, colonic and cervical cancers, were studied. Immunohistochemical methods were used to detect different markers and enzymes (CD1, CD2, CD3, CD4, CD8, CD20, CD30, CD35, CD45, l light Ig chain, lysozyme (muramidase), a-1-antichymotrypsin, protein S100 and FVIIIR). Results indicate that failure of local immunity is explained by the followings: 1. decrease in the total number of T-cells (suppressors as well as helpers); 2. high number of B-cells, plasmoblasts and antibody-forming plasmocytes, know to be able to block the cytotoxic T cells; 3. decrease in the number of incoming free phagocytes of monocytic origin and reduction in the phagocytic activity of fixed macrophages (sinus histiocytes); 4. high functional activity of dendritic reticulum cells; 5. non-handled stimulation 6. reduction in area of postcapillary venules and impairment of lymphocyte recirculation through them.

Entities:  

Year:  1997        PMID: 11173638     DOI: 10.1007/bf02907806

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  12 in total

Review 1.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

2.  Lymphadenectomy for cure in patients with early gastric cancer and lymph node metastasis.

Authors:  T Okamura; S Tsujitani; D Korenaga; M Haraguchi; H Baba; Y Hiramoto; K Sugimachi
Journal:  Am J Surg       Date:  1988-03       Impact factor: 2.565

3.  Immature sinus histiocytes. Their identification as a novel B-cell population.

Authors:  H Stein; K Lennert; D Y Mason; S Liangru; A Ziegler
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

4.  B-CLL cell surface markers and mitogen-induced thymidine uptake: a comparison between lymph node cells and peripheral blood lymphocytes in 25 patients.

Authors:  G Juliusson; K H Robèrt; P Biberfeld
Journal:  Hematol Oncol       Date:  1985 Jul-Sep       Impact factor: 5.271

5.  Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.

Authors:  Y Dohi; S Sunada; M Aoki; A Moriguchi; M Okabayashi; M Miyata; H Matsuda
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

6.  Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus.

Authors:  J D Roder; R Busch; H J Stein; U Fink; J R Siewert
Journal:  Br J Surg       Date:  1994-03       Impact factor: 6.939

7.  Pathologic correlates of prognosis in lymph node-positive breast carcinomas.

Authors:  F Clayton; C L Hopkins
Journal:  Cancer       Date:  1993-03-01       Impact factor: 6.860

8.  Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer.

Authors:  P C McGrath; L S Hamby; J W Freeman
Journal:  Am J Surg       Date:  1992-12       Impact factor: 2.565

9.  Clinical stage I adenocarcinoma of the endometrium--analysis of recurrences and the potential benefit of staging lymphadenectomy.

Authors:  J L Belinson; K R Lee; G J Badger; R G Pretorius; M A Jarrell
Journal:  Gynecol Oncol       Date:  1992-01       Impact factor: 5.482

Review 10.  Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck.

Authors:  F de Braud; M al-Sarraf
Journal:  Semin Oncol       Date:  1993-06       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.